HANGZHOU, China , July 30, 2024 /PRNewswire/ -- China Jo-Jo Drugstores, Inc. (Nasdaq: CJJD) ("Jo-Jo Drugstores" or the "Company"), a leading online and offline retailer, wholesale distributor of pharmaceutical and other healthcare products and healthcare provider in China, today announced its financial results for the fiscal year ended March 31, 2024. Mr. Lei Liu, Chairman and CEO of Jo-Jo Drugstores, commented, "We are pleased to present our financial performance for fiscal year 2024, which reflects our commitment to maintaining a resilient business model in a dynamic market.
HANGZHOU, China , June 11, 2024 /PRNewswire/ -- China Jo-Jo Drugstores, Inc. (Nasdaq: CJJD) ("Jo-Jo Drugstores" or the "Company"), a leading online and offline retailer, wholesale distributor of pharmaceutical and other healthcare products and healthcare provider in China, today announced that it has entered into definitive agreements with a number of investors providing for the issuance of 1,980,000 million ordinary shares, at a purchase price of $1.70 per share, in a registered direct offering for an aggregate gross proceeds of approximately $3.37 million. The closing of the sale of the securities is expected to occur on or about June 26, 2024, subject to satisfaction of customary closing conditions.
HANGZHOU, China , May 31, 2024 /PRNewswire/ -- China Jo-Jo Drugstores, Inc. (Nasdaq: CJJD) ("Jo-Jo Drugstores" or the "Company"), a leading online and offline retailer, wholesale distributor of pharmaceutical and other healthcare products and healthcare provider in China, today announced that Ms. Pingfan Wu has resigned from her position as a member of the board of directors (the "Board") due to personal reasons, effective on May 31, 2024.
19 Feb 2024 Date | | - Cons. EPS | - EPS |
12 Feb 2024 Date | | - Cons. EPS | - EPS |
27 Nov 2023 Date | | - Cons. EPS | - EPS |
20 Nov 2023 Date | | - Cons. EPS | - EPS |
13 Nov 2023 Date | | - Cons. EPS | - EPS |
19 Feb 2024 Date | | - Cons. EPS | - EPS |
12 Feb 2024 Date | | - Cons. EPS | - EPS |
27 Nov 2023 Date | | - Cons. EPS | - EPS |
20 Nov 2023 Date | | - Cons. EPS | - EPS |
13 Nov 2023 Date | | - Cons. EPS | - EPS |
Medical - Pharmaceuticals Industry | Healthcare Sector | Lei Liu CEO | NASDAQ (CM) Exchange | G2124G120 Cusip |
CN Country | 939 Employees | - Last Dividend | 1 Mar 2024 Last Split | 16 May 2008 IPO Date |
China Jo-Jo Drugstores, Inc., established in 2003 and headquartered in Hangzhou, the People's Republic of China, operates as a prominent retailer and distributor of pharmaceutical and healthcare products. The company's operations are diversified across four main segments: Retail Drugstores, Online Pharmacy, Drug Wholesale, and Herb Farming. With a broad network of retail pharmacies under the Jiuzhou Grand Pharmacy brand, China Jo-Jo has carved a niche for itself in the Chinese healthcare market by offering a wide range of pharmaceutical products, leveraging traditional Chinese medicines (TCM), and providing professional medical consultations and treatments.